Kang Sang Min, Lee Sang Won, Jeong Hak Jun, Yoon San Hyun, Lim Jin Ho, Lee Seong Goo
Daegu Maria Fertility Clinic, Daegu, Korea.
Clin Exp Reprod Med. 2011 Mar;38(1):53-60. doi: 10.5653/cerm.2011.38.1.53. Epub 2011 Mar 31.
This study was carried out to compare the clinical outcome of elective single cleavage-embryo transfer (eSCET) to that of elective single blastocyst-embryo transfer (eSBET) in human IVF-ET.
This study was a retrospective study which analyzed for 614 women who visited the Daegu Maria Clinic from August 2008 to December 2009. All were under 37 years old and had more than 8 mm of endometrial thickness on the day of hCG administration and at least one good quality embryo on day 3. The eSCETs were performed on day 3 (n=450) and the eSBETs were conducted on day 5 (n=164).
The numbers of retrieved oocytes, fertilized oocytes, and day 3 good quality embryos were significantly lower in the eSCET group (12.1±6.0, 8.2±4.6, and 4.2±3.1, respectively) compared to the eSBET group (16.7±7.2, 12.1±5.0, and 8.5±4.5, respectively; p<0.001). However, the clinical pregnancy, implantation, on-going pregnancy, and live birth rates of the eSCET group (46.7, 46.9, 40.0, and 36.7%, respectively) were not statistically different from those of the eSBET group (51.2, 51.8, 45.1, and 43.9%, respectively; p=0.318, 0.278, 0.254, and 0.103, respectively).
These results suggested that elective single embryo transfer should be performed regardless of the developmental stage to women less than 37 years old who had more than 8 mm of endometrial thickness on the hCG administration day and at least one good quality embryo on day 3 in order to reduce the twin pregnancy rate without reducing the whole pregnancy rate.
本研究旨在比较人类体外受精 - 胚胎移植(IVF - ET)中选择性单卵裂期胚胎移植(eSCET)与选择性单囊胚期胚胎移植(eSBET)的临床结局。
本研究为回顾性研究,分析了2008年8月至2009年12月期间就诊于大邱玛利亚诊所的614名女性。所有女性年龄均在37岁以下,在注射人绒毛膜促性腺激素(hCG)当天子宫内膜厚度超过8毫米,且在第3天至少有一个优质胚胎。eSCET在第3天进行(n = 450),eSBET在第5天进行(n = 164)。
与eSBET组相比,eSCET组回收的卵母细胞、受精的卵母细胞和第3天优质胚胎的数量显著更低(分别为12.1±6.0、8.2±4.6和4.2±3.1)(eSBET组分别为16.7±7.2、12.1±5.0和8.5±4.5;p<0.001)。然而,eSCET组的临床妊娠率、着床率、持续妊娠率和活产率(分别为46.7%、46.9%、40.0%和36.7%)与eSBET组(分别为51.2%、51.8%、45.1%和43.9%)在统计学上无差异(p分别为0.318、0.278、0.254和0.103)。
这些结果表明,对于在hCG注射当天子宫内膜厚度超过8毫米且在第3天至少有一个优质胚胎的37岁以下女性,为了降低双胎妊娠率而不降低总体妊娠率,无论胚胎发育阶段如何,都应进行选择性单胚胎移植。